Company intelligence / Profile preview

Solas BioVentures

Chattanooga, Tennessee, United Statessolasbio.com ↗

Ownership: Private
Development stage: Other

Overview

Solas BioVentures does not develop its own therapeutics or devices but invests in early-stage life sciences companies. Its investment focus includes biopharma, medical devices, diagnostics, and regulated digital health. The firm leverages deep sector expertise to identify innovations that can transform patient outcomes and deliver strong returns for investors. No direct clinical results as it does not run trials itself.

Modalities: BiopharmaceuticalsMedical DevicesDiagnosticsDigital Health Technologies
Industry: Investors

Partnerships

Sower Group (Sower Solas I LP Fund partnership)

Beyond the preview

Go deeper on Solas BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solas BioVentures.

Explore the full profile